Patent · US Active

LRP-8 binding dual variable domain immunoglobulin proteins

US10093733B2 · kind B2 · utility

0Cited by
168References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2015
Grant dateOct 9, 2018
Priority date
Expiry dateDec 11, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides binding proteins that specifically bind to LRP-8 and optionally cross the blood brain barrier (BBB), localize to the brain and/or localize to the spinal cord.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.